cerebral atherosclerosis: Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
450 |
4. Check minimum number of eventsNone |
450 |
5. Include endpointsNone |
450 |
6. Filter based on genotype QC (FinnGen only) |
450 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- I67
- Name in latin
- Atherosclerosis cerebralis
Similar endpoints
↥List of similar endpoints to
Cerebral atherosclerosis
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases (FINNGEN)
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases (excluding rheumatic etc)
- Cardiovascular diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 13448 | 6688 | 6394 |
| Only index persons | 3338 | 1814 | 1524 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.19 | 0.19 | 0.18 |
| Only index persons | 0.06 | 0.07 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 76.04 | 77.52 | 74.70 |
| Only index persons | 76.30 | 78.24 | 74.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 450 | 165 | 285 |
| Unadjusted period prevalence (%) | 0.10 | 0.06 | 0.13 |
| Median age at first event (years) | 73.48 | 73.82 | 73.29 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 391
- Matched controls
- 3909
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I67.2
ICD-10 Finland
Cerebral atherosclerosis
10427.9
323.0
321
*
4370A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral atherosclerosis
+∞
40.3
38
*
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.5
21.0
82
219
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.8
18.7
88
277
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
4.0
18.3
81
241
43700
ICD-8 Finland
Generalised ischaemic cerebrovascular disease, With hypertension (benign)
+∞
17.8
17
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
9.7
16.8
34
38
43799
ICD-8 Finland
Generalised ischaemic cerebrovascular disease, Without mention of hypertension
+∞
15.7
15
*
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
7.2
15.7
38
57
AA1AD
NOMESCO Finland
CT of head and brain
2.6
15.4
139
676
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.9
14.4
103
432
B01AC04
ATC
clopidogrel; oral
2.6
12.9
113
532
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
5.0
12.7
41
89
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.4
12.1
44
108
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
9.6
11.1
22
24
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
17.2
9.9
15
9
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
3.8
9.7
41
117
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.2
9.1
34
87
B01AC07
ATC
dipyridamole; systemic
2.8
8.9
60
239
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
9.8
8.8
17
18
F01.9
ICD-10 Finland
Vascular dementia, unspecified
5.1
8.5
26
54
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
6.9
8.4
20
30
C10AA05
ATC
atorvastatin; oral
1.9
8.4
169
1107
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
8.8
8.4
17
20
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
7.8
150
961
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
9.6
7.3
14
15
TAB00
NOMESCO Finland
Lumbar puncture
5.5
7.2
20
38
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
4.3
6.9
24
58
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.5
6.8
53
230
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
6.7
39
142
XA800
NOMESCO Finland
Neuropsychological investigation
6.6
6.7
16
25
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.7
6.6
27
76
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.0
6.6
87
481
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.4
6.5
56
254
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
70.7
6.4
7
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
101
525
2.18
9.95
2.5
1.8
29.2
29.6
s
0.51
101
503
88
501
1.93
6.59
2.5
2.9
0.8
0.8
mmol/l
0.77
79
458
198
1492
1.58
5.21
7.6
5.2
1.2
1.2
mmol/l
1.13
186
1320
208
1621
1.52
4.51
7.9
6.0
1.2
1.2
mmol/l
0.93
160
1322
100
674
1.62
4.07
5.6
3.9
514.8
226.3
ng/l
0.29
90
594
92
612
1.63
3.94
1.9
1.8
—
—
—
0
0
51
288
1.86
3.89
5.1
3.8
1.2
1.2
mmol/l
0.70
45
242
177
1373
1.47
3.74
2.5
2.1
94.3
90.6
pmol/l
0.53
103
716
119
852
1.53
3.71
1.9
1.6
20.4
20.7
nmol/l
0.05
105
708
110
789
1.52
3.37
1.9
1.8
1063.9
1173.3
nmol/l
0.67
84
579
223
1846
1.40
3.16
7.4
4.7
7.2
6.9
mmol/l
0.73
211
1736
75
505
1.58
3.04
3.5
2.4
2.2
2.2
g/l
0.02
66
462
44
257
1.78
3.04
2.2
1.7
—
—
—
0
0
26
129
2.07
2.89
2.4
2.1
576.4
883.3
ug/l
0.28
26
120
54
344
1.64
2.75
3.9
3.8
2.6
1.9
mmol/l
0.73
43
268
78
546
1.51
2.66
3.6
2.3
9.3
11.8
umol/l
2.80
70
502
0
69
0.00
2.62
0.0
3.8
—
526.6
—
0
64
19
87
2.23
2.59
1.4
1.4
—
—
—
0
0
190
1570
1.36
2.56
3.4
3.0
55.8
56.6
u/l
0.03
181
1428
13
50
2.64
2.53
2.2
2.0
—
—
—
0
0
57
377
1.58
2.50
5.8
4.0
—
—
—
0
0
104
781
1.43
2.48
1.9
1.8
443.3
9223736.5
pmol/l
0.50
87
618
63
429
1.54
2.44
1.9
1.8
—
—
—
0
0
63
432
1.53
2.37
1.9
1.8
—
—
—
0
0
162
1322
1.35
2.32
5.5
4.4
—
—
—
0
0
29
164
1.81
2.26
5.1
4.1
25.6
23.8
mmol/l
1.96
24
146
116
902
1.38
2.25
2.9
2.2
2.8
3.3
mg/l
1.66
105
755
45
290
1.61
2.21
1.8
2.1
0.2
0.2
g/l
0.37
40
261
61
424
1.50
2.16
7.5
5.8
1.3
1.3
mmol/l
0.00
54
324
171
1426
1.31
2.07
6.0
4.1
33.2
34.2
g/l
1.21
159
1310
36
224
1.65
2.04
1.8
1.5
—
—
—
0
0
12
50
2.43
2.02
1.0
1.2
—
—
—
0
0
67
482
1.45
2.01
3.7
2.4
15.8
21.1
%
3.52
49
415
168
1403
1.31
2.00
6.1
4.3
116.2
42.9
ng/l
0.68
141
1094
50
341
1.52
1.95
3.3
3.0
247.5
283.6
ng/l
0.22
42
313
17
85
2.03
1.91
1.1
1.3
—
—
—
0
0
17
85
2.03
1.91
1.1
1.3
—
—
—
0
0
51
352
1.50
1.88
2.4
2.6
5.3
9.5
umol/l
3.36
44
310
170
1432
1.29
1.87
5.2
4.3
0.0
0.0
estimate
0.00
41
283
189
1615
1.29
1.86
5.4
5.6
11.5
12.5
umol/l
0.70
176
1521
169
1431
1.28
1.77
7.0
5.8
0.0
0.0
estimate
0.00
41
274
5
13
3.86
1.71
1.0
1.0
571.0
141.0
u/l
—
5
13
139
1154
1.29
1.68
4.0
2.7
113.6
162.5
ug/l
3.00
130
1026
170
1448
1.27
1.68
5.2
4.3
0.0
0.0
estimate
0.49
39
269
23
134
1.75
1.67
3.3
3.1
—
—
—
0
0
11
49
2.27
1.63
1.4
1.1
10.3
15.6
e6/l
—
6
40
30
190
1.61
1.62
1.5
1.6
2.0
1.6
%
0.64
24
156
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
128
1.75
1.61
4.6
2.2
0.3
0.3
u/ml
0.08
16
70
14
71
2.00
1.54
4.5
1.5
—
—
—
0
0
16
86
1.89
1.51
1.2
1.2
—
—
—
0
0
16
86
1.89
1.51
1.2
1.2
—
—
—
0
0
229
2040
1.24
1.49
6.9
5.2
17.4
3917.9
e6/l
—
5
53
21
124
1.72
1.48
1.1
1.3
—
—
—
0
0
28
180
1.59
1.45
1.5
1.8
1.7
1.7
g/l
0.03
23
160
5
16
3.14
1.43
5.0
4.1
211.0
244.9
u/l
—
5
16
24
370
0.63
1.43
9.5
8.7
—
—
—
0
0
11
53
2.09
1.38
1.3
1.2
463.0
536.6
mg/l
0.37
11
48
52
385
1.39
1.37
1.3
1.2
18.6
44.0
iu/ml
1.99
19
126
183
1610
1.22
1.29
7.7
7.9
4.6
4.4
e9/l
0.32
160
1398
39
279
1.43
1.25
2.7
2.1
30.1
32.8
u/l
0.24
33
219
8
38
2.12
1.18
1.4
1.3
0.9
0.5
nmol/l
—
8
33
140
1208
1.22
1.18
4.3
3.6
—
—
—
0
0
15
87
1.74
1.15
2.1
2.6
14.8
84.7
ug/min
—
8
55
16
95
1.70
1.14
1.4
1.6
—
—
—
0
0
8
40
2.01
1.12
1.1
5.5
—
166.8
—
0
5
102
857
1.24
1.10
3.4
2.9
45.5
38.0
u/l
0.25
91
821
9
45
2.01
1.05
3.0
4.1
—
—
—
0
0
17
107
1.61
1.00
1.2
1.3
—
—
—
0
0
66
536
1.27
0.96
3.6
3.4
6.0
2.3
e6/l
0.39
32
314
51
401
1.30
0.95
3.8
3.6
228.6
248.1
u/l
1.05
46
375
109
940
1.21
0.92
4.4
3.5
0.7
0.6
e6/l
0.13
79
716
59
476
1.27
0.91
1.4
1.2
0.8
1.2
u/ml
—
10
126
25
180
1.41
0.82
3.1
2.5
0.8
0.7
%
1.26
25
175
6
32
1.88
0.81
1.0
1.0
—
—
u/ml
—
0
0
137
1224
1.17
0.77
2.7
2.2
—
—
—
0
0
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
94
817
1.19
0.73
6.0
4.6
0.0
0.0
estimate
0.00
39
267
251
2650
0.87
0.73
5.9
5.0
6.3
6.2
mmol/l
0.90
231
2333
127
1137
1.16
0.69
5.9
4.7
—
—
—
0
0
30
231
1.32
0.68
1.7
1.8
—
—
—
0
0
10
61
1.65
0.68
5.2
3.2
52.4
60.7
%
—
10
61
5
28
1.79
0.66
1.8
2.5
583.0
515.8
ml
—
5
18
65
553
1.20
0.65
3.7
3.2
0.8
1.3
e6/l
1.02
31
326
78
676
1.18
0.64
2.9
3.0
2.5
2.5
mmol/l
0.07
67
585
5
29
1.73
0.63
1.2
1.4
—
—
—
0
0
275
2861
0.89
0.55
13.3
10.6
25.2
24.2
u/l
0.41
265
2727
15
107
1.41
0.55
1.2
1.8
31.7
39.5
u/l
1.30
15
91
224
2108
1.12
0.55
5.0
4.1
14.5
15.8
mm/h
0.58
213
1897
213
2000
1.12
0.54
4.2
3.7
14.7
15.1
pmol/l
1.41
195
1729
20
151
1.33
0.54
1.7
2.0
—
—
—
0
0
17
125
1.37
0.53
2.4
4.3
23.8
25.2
mmol/l
1.34
17
116
9
62
1.46
0.53
1.3
1.4
—
—
—
0
0
6
96
0.62
0.52
1.8
1.9
—
—
—
0
0
73
642
1.16
0.51
5.3
4.9
1.0
1.0
kg/l
0.61
19
98
31
251
1.25
0.51
4.9
3.6
95.4
91.1
ng/l
0.10
26
216
32
386
0.81
0.50
2.6
3.9
2.5
39.5
ug/l
1.18
26
335
66
745
0.86
0.50
2.6
3.1
0.9
0.8
ug/l
0.13
52
515
29
234
1.25
0.49
2.2
3.1
54.2
57.6
ml/min/173m2
—
10
103
88
788
1.14
0.49
3.3
2.8
5192.9
8657.5
umol/l
0.29
77
646
13
93
1.40
0.48
1.5
1.4
—
—
—
0
0
79
705
1.14
0.46
3.1
2.5
—
—
—
0
0
128
1181
1.11
0.44
2.6
2.2
78.9
78.5
nmol/l
0.06
118
1024
256
2655
0.91
0.44
6.6
5.3
2.2
2.5
mmol/l
5.07
248
2359
8
55
1.46
0.43
1.3
1.2
0.7
0.8
nmol/l
—
8
45
8
56
1.43
0.42
1.0
1.0
—
20.5
—
0
5
287
2957
0.91
0.42
38.5
26.4
128.4
131.6
g/l
3.03
280
2886
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
3.9
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
7
104
0.67
0.40
1.1
2.6
40.1
40.4
u/ml
—
7
99
19
234
0.80
0.37
1.4
1.3
—
—
—
0
0
71
640
1.13
0.37
2.0
1.7
1.0
1.5
mg/l
2.64
59
511
6
42
1.43
0.35
1.2
1.4
228.7
239.8
u/l
—
6
42
16
198
0.80
0.33
1.4
1.4
—
—
—
0
0
6
47
1.28
0.32
1.3
1.2
—
—
—
0
0
249
2563
0.93
0.31
5.8
4.7
4.0
4.4
mmol/l
6.66
237
2298
117
1094
1.09
0.31
3.2
3.0
2.3
2.3
mmol/l
0.01
104
934
7
55
1.27
0.30
1.1
1.2
20.7
60.4
u/l
—
7
46
247
2534
0.94
0.27
5.7
4.6
1.4
1.4
mmol/l
2.22
233
2242
8
66
1.21
0.26
1.4
1.5
—
—
—
0
0
8
67
1.19
0.26
1.3
1.4
—
—
—
0
0
99
1044
0.93
0.24
4.7
4.6
21.8
21.6
%
0.04
47
538
235
2275
1.06
0.24
8.5
7.0
78.1
81.8
u/l
0.63
222
2114
246
2516
0.94
0.23
26.1
17.5
69.1
70.1
ml/min/173m2
0.28
213
2101
12
97
1.24
0.22
1.2
1.0
—
—
—
0
0
286
2910
0.94
0.22
33.1
21.6
4.0
4.0
mmol/l
0.03
278
2813
5
42
1.19
0.21
1.4
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
3.0
—
2.8
—
0
5
0
10
0.00
0.21
0.0
1.4
—
10.0
—
0
5
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.8
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
286
2906
0.95
0.20
32.7
21.5
139.2
139.6
mmol/l
1.50
278
2810
6
51
1.17
0.19
1.5
1.6
—
—
—
0
0
17
146
1.17
0.19
2.0
1.8
—
—
—
0
0
128
1227
1.06
0.18
3.5
3.2
2673.2
2257.6
ng/l
0.30
112
1058
7
62
1.13
0.17
2.0
1.4
—
—
—
0
0
255
2492
1.05
0.16
5.5
4.6
2.2
2.0
mu/l
0.59
235
2175
282
2768
1.04
0.13
26.7
18.2
26.1
28.4
mg/l
0.58
257
2297
15
132
1.14
0.12
1.9
1.6
—
—
—
0
0
243
2459
0.97
0.11
5.3
4.2
1.3
1.2
mmol/l
0.53
231
2159
129
1318
0.97
0.10
4.7
5.3
2.4
4.3
ug/l
1.12
114
1141
70
673
1.04
0.09
1.7
1.6
1.3
1.3
mmol/l
0.17
54
539
6
57
1.05
0.08
1.3
1.6
—
—
—
0
0
37
356
1.04
0.04
1.4
1.2
0.9
16.1
u/ml
—
10
125
56
546
1.03
0.03
31.3
29.9
1.6
1.5
inr
—
5
63
255
2556
0.99
0.03
7.4
6.5
42.4
41.8
mmol/mol
0.41
246
2325
234
2335
1.00
0.00
31.0
19.6
35.8
37.9
%
1.37
143
1412
97
965
1.00
0.00
4.5
3.9
11.9
10.3
mg/mmol
0.11
68
614
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
78
0.89
0.00
1.4
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
119.0
—
0
5
0
5
0.00
0.00
0.0
1.0
—
1444.8
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.6
—
13.7
—
0
7
6
61
0.98
0.00
1.3
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
0.00
1.4
1.6
—
—
—
0
0
5
50
1.00
0.00
1.4
1.6
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
8.7
—
0
6
5
49
1.02
0.00
1.0
1.1
—
—
—
0
0
8
79
1.01
0.00
1.3
1.6
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
90.0
—
0
9
8
82
0.97
0.00
1.3
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_CEREBATHER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBATHER | 2.047 [1.71, 2.45] | < 0.001 |
| Birth year | 0.993 [0.98, 1.0] | 0.133 |
During the follow-up period (1.1.1998 — 31.12.2019), 756 out of 1228 females with I9_CEREBATHER died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBATHER | 2.466 [1.9, 3.21] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 656 out of 1080 males with I9_CEREBATHER died.
Mortality risk
Mortality risk for people of age
years, who have I9_CEREBATHER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.185% | 0.353% |
| 5 | 1.028% | 2.747% |
| 10 | 2.745% | 6.72% |
| 15 | 5.394% | 11.925% |
| 20 | 9.426% | 19.076% |
Relationships between endpoints
↥Index endpoint: I9_CEREBATHER – Cerebral atherosclerosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data